Works matching IS 21938210 AND DT 2022 AND VI 12 AND IP 3
Results: 16
Rapidity of Improvement in Signs/Symptoms of Moderate-to-Severe Atopic Dermatitis by Body Region with Abrocitinib in the Phase 3 JADE COMPARE Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 771, doi. 10.1007/s13555-022-00694-1
- By:
- Publication type:
- Article
Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 761, doi. 10.1007/s13555-022-00693-2
- By:
- Publication type:
- Article
Demographic and Clinical Factors Associated with Patient-Reported Remission in Psoriasis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 753, doi. 10.1007/s13555-022-00692-3
- By:
- Publication type:
- Article
Characteristics of New Biologic Users Among the Moderate-to-Severe Psoriasis Population—Retrospective Cohort Study Leveraging the Modernizing Medicine Data Services Database.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 741, doi. 10.1007/s13555-022-00691-4
- By:
- Publication type:
- Article
Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 727, doi. 10.1007/s13555-022-00690-5
- By:
- Publication type:
- Article
A Case of New-Onset Lichen Planus after COVID-19 Vaccination.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Effectiveness of Cimetidine as Adjuvant Therapy in the Treatment of Acute-Extrinsic Atopic Dermatitis: A Double-Blind Randomized Controlled Trial.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 715, doi. 10.1007/s13555-022-00688-z
- By:
- Publication type:
- Article
A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 787, doi. 10.1007/s13555-022-00687-0
- By:
- Publication type:
- Article
A Retrospective Cohort Analysis of Treatment Patterns Over 1 Year in Patients with Psoriasis Treated with Ixekizumab or Guselkumab.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 701, doi. 10.1007/s13555-022-00686-1
- By:
- Publication type:
- Article
An Emollient PLUS Balm Is Useful for the Management of Xerosis in Patients Treated for Cancer: A Real-World, Prospective, Observational, Multicenter Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 683, doi. 10.1007/s13555-022-00685-2
- By:
- Publication type:
- Article
Dimethyl Fumarate's Effectiveness and Safety in Psoriasis: A Real-Life Experience During the COVID-19 Pandemic.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 671, doi. 10.1007/s13555-022-00684-3
- By:
- Publication type:
- Article
Atopic Dermatitis and Psoriasis are Diagnosed Clinically and Treated Empirically.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 611, doi. 10.1007/s13555-022-00683-4
- By:
- Publication type:
- Article
Risk for Hepatitis B Virus Reactivation in Patients with Psoriasis Treated with Biological Agents: A Systematic Review and Meta-Analysis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 655, doi. 10.1007/s13555-022-00682-5
- By:
- Publication type:
- Article
Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 643, doi. 10.1007/s13555-022-00681-6
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, Efficacy, and Biomarker Profiles During Nemolizumab Treatment of Atopic Dermatitis in Adolescents.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 631, doi. 10.1007/s13555-021-00678-7
- By:
- Publication type:
- Article
Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 3, p. 615, doi. 10.1007/s13555-021-00655-0
- By:
- Publication type:
- Article